Open Beta
MetriLume

US marketsRMTG

SEC-sourced researchBeta

RMTG

Regenerative Medical Technology Group Inc.

Company comparison ↗

Data passport

CIK
0001760026
Exchange
OTC
Business activity
— · SIC 5990
Financial inputs
6/6
Filing date
Aug 28, 2026
SEC registry record
Operating company

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2024: 4,107,494.0000 USD; December 2025: 5,100,315.0000 USD5.1M USD0 USD0December 2024December 2025
RMTG · Exact amounts and source periods · USD
Period endRevenueFiling date
December 20244,107,494.0000May 14, 2026
December 20255,100,315.0000May 14, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 20255,100,315.0000-7,812,409.0000-706,519.00004,488,694.000039,233,729.0000May 14, 2026
December 20244,107,494.0000-5,562,971.0000850,699.00003,821,429.000031,178,102.0000May 14, 2026

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenues$5.1MDecember 2025May 14, 202610-K
Previous period revenueRevenues$4.11MDecember 2024May 14, 202610-K
Net incomeNetIncomeLoss-$7.81MDecember 2025May 14, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities-$706.52KDecember 2025May 14, 202610-K
Total assetsAssets$4.49MDecember 2025May 14, 202610-K
Total liabilitiesLiabilities$39.23MDecember 2025May 14, 202610-K

New filings

Explore methodology ↗